Osaic Holdings
OKYO

Osaic Holdings’s OKYO Pharma OKYO Stock Holding History

Osaic Holdings’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244 Hold
152
– – ﹤0.01% 7536
2025
Q4 		$314 Hold
152
– – ﹤0.01% 7514
2025
Q3 		$304 Buy
+152
New +$387 ﹤0.01% 7637

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Osaic Holdings's OKYO Position: Q1 2026 in Review

Osaic Holdings held its OKYO Pharma (OKYO) position steady in Q1 2026 at 152 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #7536.

Osaic Holdings first reported a position in OKYO in Q3 2025 and has held it in 3 quarters since. The position peaked at $314 in Q4 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Osaic Holdings held 152 shares of OKYO Pharma worth $244 as of Q1 2026.
  • Osaic Holdings left its OKYO Pharma share count unchanged in Q1 2026.
  • OKYO Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7536 holding.
  • Osaic Holdings first reported a position in OKYO Pharma in Q3 2025 and has held it in 3 quarters since.
  • Osaic Holdings's OKYO Pharma position peaked at $314 in Q4 2025.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.